A View from Corie Lok

Early Success for Malaria Vaccine

A malaria vaccine tested in more than 2,000 Mozambique children cut the risk of developing the disease by 30 percent and lowered the incidence of life-threatening episodes by 58 percent, according to Healthday.com. One NIH official is quoted as saying…

  • October 15, 2004

A malaria vaccine tested in more than 2,000 Mozambique children cut the risk of developing the disease by 30 percent and lowered the incidence of life-threatening episodes by 58 percent, according to Healthday.com. One NIH official is quoted as saying this is “a major advance.”

These are the first early results (published today in The Lancet; registration required) from the largest pediatric malaria vaccine trial done in Africa and are the first to show some benefit of a malaria vaccine for kids. This is hope for a field that hasn’t had much success in developing a vaccine for a disease that kills 3000 children each day. (My colleague Erika Jonietz wrote about new malaria vaccines, including this one, a few months back.)

It won’t be until the end of the decade at the earliest that we might see a malaria vaccine approved. Let’s just hope that GlaxoSmithKline, the drug company that co-developed this vaccine and has said it’s committed to making this vaccine a reality, will actually follow through on its promise, considering how unlucrative the vaccine business is. It’s doubtful the company will be able to supply the vaccine affordably to everyone who needs it without help from richer nations.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

Want more award-winning journalism? Subscribe and become an Insider.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look: exclusive early access to important stories, before they’re available to anyone else

    Insider Conversations: listen in on in-depth calls between our editors and today’s thought leaders

  • Insider Plus {! insider.prices.plus !}* Best Value

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus ad-free web experience, select discounts to partner offerings and MIT Technology Review events

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning magazine and daily delivery of The Download, our newsletter of what’s important in technology and innovation.

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.